Health Care & Life Sciences » Biotechnology | Circassia Pharmaceutical PLC

Circassia Pharmaceutical PLC

Circassia Pharmaceutical PLC
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
357.23 M
Public Float
-

Profile

Address
Northbrook House
Oxford Oxfordshire OX4 4GA
United Kingdom
Employees -
Website http://circassia.com
Updated 07/08/2019
Circassia Pharmaceuticals Plc is a biopharmaceutical company, which engages in the development and commercialization of allergy, asthma, and respiratory products. It operates through the following segments: NIOX, Respiratory, and US AZ Collaboration. The NIOX segment provides a portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide.

Financials

View All
Created with Highcharts 5.0.14Circassia Pharmaceutical PLCNet Income. Fiscal year is January-December. All values GBP Thousands.19 98119 98135 10835 10849 90049 90036 80036 80093 60093 60046 60046 600201320142015201620172018025k50k75k100k
Created with Highcharts 5.0.14Circassia Pharmaceutical PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.000010 80010 80023 10023 10046 30046 30048 30048 300201320142015201620172018010k20k30k40k50k60k

Francesco Granata
Chairman
Steven Charles Andrew Harris
Chief Executive Officer & Executive Director